Welcome to our dedicated page for Siriuspoint SEC filings (Ticker: SPNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SiriusPoint Ltd. (SPNT) SEC filings page on Stock Titan brings together the company’s U.S. regulatory disclosures, including current reports on Form 8-K and other key documents filed with the Securities and Exchange Commission. SiriusPoint is a Bermuda-incorporated global underwriter of insurance and reinsurance whose common shares and 8.00% Resettable Fixed Rate Preference Shares, Series B, are listed on the New York Stock Exchange under the symbols SPNT and SPNT PB. Its filings provide detailed insight into segment performance, capital structure, governance, and material corporate events.
Through its Form 8-K filings, SiriusPoint reports results of operations and financial condition, furnishing earnings press releases, financial supplements, and investor presentations for periods such as the second and third quarters. These documents explain Core results across the Insurance & Services and Reinsurance segments, combined ratios, underwriting income, Core net services income, and book value measures, as well as the impact of catastrophe losses and prior-year reserve development.
The company also uses Form 8-K to disclose material transactions and strategic actions, including the definitive agreement and subsequent completion of the sale of ArmadaCorp Capital, LLC, the holding company of supplemental health insurance program manager ArmadaCare, and the agreement to sell its equity stake in Arcadian Holdings Limited to an acquisition vehicle affiliated with Lee Equity Partners. Related exhibits often include press releases describing associated capacity agreements that extend underwriting authority for Arcadian through at least the end of 2031.
Additional filings cover governance and compensation matters, such as the adoption of the SiriusPoint Ltd. Executive Severance Plan, appointments and resignations of executive officers and directors, and determinations about director independence. SiriusPoint also files 8-Ks to announce quarterly cash dividends on its Series B preference shares, specifying dividend amounts, record dates, and payment dates.
On Stock Titan, these SEC filings are updated as they are released on EDGAR, and AI-powered summaries can help explain the significance of each report. Users can quickly see which filings relate to earnings (such as 10-Q and 10-K when available), which detail insider and executive changes, and which describe major transactions or capital actions, providing a structured view of SiriusPoint’s regulatory history.
Govrin David E. reported acquisition or exercise transactions in this Form 4 filing.
SiriusPoint Ltd Group President David E. Govrin reported an equity award of 315,738 common shares at a stated price of
SiriusPoint Ltd Group Chief Underwriting Officer Anthony Shapella reported a tax-related share disposition. On February 27, 2026, 2,248 common shares were withheld to cover current tax liabilities tied to the vesting of restricted shares. Following this, he directly owns 39,967 common shares, including restricted shares.
SiriusPoint Ltd reported that Chief Executive Officer Scott Egan acquired 776,096 common shares on February 26, 2026 through a grant/award at a price of $0.00 per share. This reflects performance-based equity compensation rather than an open-market purchase.
A footnote explains the award represents performance restricted share units from a 2023–2025 grant that achieved 200% of target and will vest on April 14, 2026. After this award, Egan directly holds 1,015,179 common shares, and separately reports indirect ownership of 545,083 shares held through Egan Family Investment Ltd.
SiriusPoint Ltd executive Robin Gibbs, CEO of SiriusPoint International, reported an acquisition of 153,988 common shares on a no-cash basis. These shares represent Performance Restricted Share Units earned at 200% of target under a 2023–2025 grant. Following this award, Gibbs holds 234,586 common shares in total, which the company notes include restricted shares. The performance share units are scheduled to vest on April 14, 2026.
SiriusPoint Ltd has had its 8.00% Resettable Fixed Rate Preference Shares, Series B removed from listing and registration on the New York Stock Exchange LLC. The Exchange states it complied with Rule 17 CFR 240.12d2-2 and that the issuer complied with the Exchange's withdrawal requirements.
SiriusPoint Ltd. reports on its 2025 performance as a global specialty insurance and reinsurance underwriter headquartered in Bermuda. The company had common shareholders’ equity of
Core underwriting income reached
Investment results were strong at
SiriusPoint Ltd. reported very strong fourth-quarter and full-year 2025 results, highlighting profitable growth and capital returns. Net income available to common shareholders reached $240 million in Q4, or $1.97 per diluted share, with operating earnings per share of $0.70. Annual net income was $444 million, or $3.64 per diluted share, and operating earnings per share rose 49% to $2.55. The company delivered an annualized return on equity of 44.9% in Q4 and 22.1% for the year, with operating ROE of 16.2%. Gross written premiums grew 16% in 2025 and the Core combined ratio was 91.7%, indicating solid underwriting profitability.
Book value per common share increased to $19.40, while book value per diluted share excluding AOCI rose 23.6% to $18.10. SiriusPoint announced it will redeem all Series B preference shares, expecting its leverage ratio to fall to about 23%, and plans to repurchase $100 million of common shares over the next 12 months. The balance sheet remained strong with a year-end BSCR estimate of 247%. Strategic actions included selling a 49% stake in Arcadian for $140.4 million (with an expected pre-tax gain of about $25 million in the first quarter of 2026) and agreements to acquire Assist America for approximately $42.5 million and the World Nomads travel insurance business to expand medical and travel assistance capabilities.
SiriusPoint Ltd. announced that its wholly owned subsidiary International Medical Group (IMG) has signed a definitive agreement to acquire the World Nomads travel insurance business from nib Group. World Nomads generates approximately $40 million of gross written premium and is a global travel insurance and lifestyle brand.
The deal is expected to significantly expand IMG’s travel insurance distribution, adding a broad base of independent, lifestyle, and adventure travelers and extending its reach to Australia, Brazil, and Canada. Together with IMG’s recent acquisition of Assist America, which produces around $20 million in annual assistance revenues, the combination creates an integrated travel insurance and assistance platform.
The company states that both the World Nomads and Assist America acquisitions are accretive to return on equity and earnings per share. An initial closing for the majority of World Nomads is targeted for the second or third quarter of 2026, with final closing in the second half of 2027, in each case subject to regulatory approvals and other customary conditions.
Donald Smith & Co., Inc., a Delaware investment adviser, filed a Schedule 13G reporting beneficial ownership of 8,428,966 SiriusPoint Ltd common shares, representing about 7.2% of the class. The firm has sole voting power over most of these shares and holds them for advisory clients.
The filing states the securities were acquired and are held in the ordinary course of business, not to change or influence control of SiriusPoint. No single underlying client or other person is reported to own more than five percent of SiriusPoint’s outstanding common stock.
SiriusPoint Ltd. reports that a subsidiary has completed the previously announced sale of its entire equity stake in Arcadian Holdings Limited to Comet Bidco Limited, an acquisition vehicle of funds affiliated with Lee Equity Partners. Under the Share Purchase Agreement dated October 3, 2025, SiriusPoint Bermuda Insurance Company Ltd., as seller, received cash consideration of